GUYER WILLIAM (Chief Development Officer) sold 94.2% of their position (20K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $817.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2026ACC: 0001193125-26-039717
Officer· Chief Development Officer
Since Aug 2021
-20K
Net shares
Net seller
$817.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
$21.65
Trade value
$433K
% of position
1619.4%
2/3/2026
1.24K→21.23K
Common Stock
Direct
Shares
−20K
Price / share
$40.87
Trade value
$817.33K
% of position
94.2%
2/3/2026
21.23K→1.24K
Total
Net shares
+0.00
Net value
-$384.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +20K | $21.65 | $433K | 1619.4% | 1.24K | 21.23K |
| Common Stock Direct | 2/3/2026 | S · Sale | −20K | $40.87 | $817.33K | 94.2% | 21.23K | 1.24K |
| Total | +0.00 | -$384.33K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
−20K
Strike price
21.65
Held after
230K
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock20K shares | 2/3/2026 | M · Option Exercise | −20K | 21.65 | — | 230K |